NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ
NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ
复制标题
NLRC5 抑制血管损伤后新内膜形成并直接与 PPAR gamma 相互作用
DOI:
10.1038/s41467-019-10784-y
复制
发表时间:
2019-06-28
影响因子:
16.6
通讯作者:
Peng, Wenhui
中科院分区:
文献类型:
--
作者:
Luan, Peipei;Jian, Weixia;Peng, Wenhui
NLR Family CARD Domain Containing 5 (NLRC5), an important immune regulator in innate immunity, is involved in regulating inflammation and antigen presentation. However, the role of NLRC5 in vascular remodeling remains unknown. Here we report the role of NLRC5 on vascular remodeling and provide a better understanding of its underlying mechanism. Nlrc5 knockout (Nlrc5(-/-)) mice exhibit more severe intimal hyperplasia compared with wild-type mice after carotid ligation. Ex vivo data shows that NLRC5 deficiency leads to increased proliferation and migration of human aortic smooth muscle cells (HASMCs). NLRC5 binds to PPAR gamma and inhibits HASMC dedifferentiation. NACHT domain of NLRC5 is essential for the interaction with PPAR gamma and stimulation of PPAR gamma activity. Pioglitazone significantly rescues excessive intimal hyperplasia in Nlrc5(-/-) mice and attenuates the increased proliferation and dedifferentiation in NLRC5-deficient HASMCs. Our study demonstrates that NLRC5 regulates vascular remodeling by directly inhibiting SMC dysfunction via its interaction with PPAR gamma.